IZAMAR DE LA GARZA: Open Payments
NPI 1982349213 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$579 in 5 payments from 4 companies in 2025. Trend: 2023 $758 · 2024 $702 · 2025 $579
Food & beverage: $579
| Company | Payments | Amount |
|---|---|---|
| Ipsen Biopharmaceuticals, Inc | 2 | $154 |
| Mirum Pharmaceuticals, Inc. | 1 | $150 |
| Madrigal Pharmaceuticals | 1 | $150 |
| Lilly USA, LLC | 1 | $125 |
Products named: Livmarli, REZDIFFRA, OMVOH, IQIRVO, Bylvay.
Industry payments across TX — which companies pay providers there.
